During the past decade, Helsinki University Central Hospital; Dep. of Pulmonary Medicine conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Helsinki University Central Hospital; Dep. of Pulmonary Medicine" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Galapagos NV" with 1 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored, "Institut für Pharmakologie und Präventive Medizin" with 1 trials sponsored and "Lars Gullestad" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Helsinki University Central Hospital; Dep. of Pulmonary Medicine" #1 collaborator was "Aarhus University Hospital" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Helsinki University Central Hospital" with 1 trials as a collaborator, "Istituto Di Ricerche Farmacologiche Mario Negri" with 1 trials as a collaborator and "Ministry of Health, Italy" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Helsinki University Central Hospital; Dep. of Pulmonary Medicine" are "Idiopathic Pulmonary Fibrosis" (2 trials), "Acute Myocardial Infarction" (1 trials), "Aortic Stenosis" (1 trials), "Aortic Valve Stenosis" (1 trials) and "Cardiac Allograft Vasculopathy" (1 trials). Many other conditions were trialed in "Helsinki University Central Hospital; Dep. of Pulmonary Medicine" in a lesser frequency.

Most popular intervention types in "Helsinki University Central Hospital; Dep. of Pulmonary Medicine" are "Drug" (6 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Atezolizumab" (1 trials), "Docetaxel" (1 trials), "Evolocumab" (1 trials) and "GLPG1205" (1 trials). Other intervention names were less common.

The vast majority of trials in "Helsinki University Central Hospital; Dep. of Pulmonary Medicine" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Helsinki University Central Hospital; Dep. of Pulmonary Medicine". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Helsinki University Central Hospital; Dep. of Pulmonary Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Helsinki University Central Hospital; Dep. of Pulmonary Medicine, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".